Variant report
Variant | nsv526262 |
---|---|
Chromosome Location | chr8:9133798-9151237 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:34)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:34 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr8:9136801-9136931 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | BACH1 | chr8:9143712-9144014 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | BACH1 | chr8:9143731-9144006 | K562 | blood: | n/a | n/a |
4 | CCNT2 | chr8:9149242-9149598 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr8:9150011-9150019 | HepG2 | liver: | n/a | n/a |
6 | CTCF | chr8:9144616-9144705 | GM10248 | blood: | n/a | n/a |
7 | CTCF | chr8:9147723-9147781 | GM10248 | blood: | n/a | n/a |
8 | CTCF | chr8:9142840-9142990 | HRPEpiC | eye: | n/a | n/a |
9 | CTCF | chr8:9139500-9139650 | NHLF | lung: | n/a | chr8:9139517-9139530 |
10 | EP300 | chr8:9133945-9134025 | K562 | blood: | n/a | n/a |
11 | FOS | chr8:9143827-9144093 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr8:9143779-9144108 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOS | chr8:9143880-9144106 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | GATA2 | chr8:9149293-9149529 | K562 | blood: | n/a | n/a |
15 | IRF1 | chr8:9136406-9136408 | K562 | blood: | n/a | n/a |
16 | JUND | chr8:9143694-9144110 | K562 | blood: | n/a | n/a |
17 | MAFF | chr8:9143650-9144048 | K562 | blood: | n/a | n/a |
18 | MAFK | chr8:9143751-9143990 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | MAFK | chr8:9143674-9144052 | K562 | blood: | n/a | n/a |
20 | MYC | chr8:9143421-9143453 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | NR2F2 | chr8:9149284-9149595 | K562 | blood: | n/a | n/a |
22 | NRF1 | chr8:9143487-9143531 | K562 | blood: | n/a | n/a |
23 | POLR2A | chr8:9139478-9139939 | H1-neurons | neurons: | n/a | n/a |
24 | POLR2A | chr8:9142900-9143020 | ProgFib | skin: | n/a | n/a |
25 | RCOR1 | chr8:9143756-9144124 | K562 | blood: | n/a | n/a |
26 | RCOR1 | chr8:9149247-9149692 | K562 | blood: | n/a | n/a |
27 | SPI1 | chr8:9148015-9148192 | K562 | blood: | n/a | n/a |
28 | STAT3 | chr8:9144412-9144522 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | TAL1 | chr8:9143735-9144082 | K562 | blood: | n/a | n/a |
30 | TAL1 | chr8:9149358-9149577 | K562 | blood: | n/a | n/a |
31 | TEAD4 | chr8:9149288-9149644 | K562 | blood: | n/a | n/a |
32 | UBTF | chr8:9142714-9142784 | K562 | blood: | n/a | n/a |
33 | UBTF | chr8:9143679-9143807 | K562 | blood: | n/a | n/a |
34 | ZNF384 | chr8:9145572-9145818 | K562 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PPP1R3B-5 | chr8:9150303-9150422 | l_3544_chr8:9150302-9155215_testes |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-1151P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1017760 | chr8:9133798-9133799 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs531183121 | chr8:9133824-9133825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191335579 | chr8:9133825-9133826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560834286 | chr8:9133875-9133876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566120881 | chr8:9133880-9133881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529775114 | chr8:9133905-9133906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115140302 | chr8:9133953-9133954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377308339 | chr8:9134027-9134028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149308609 | chr8:9134061-9134062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532331231 | chr8:9134071-9134072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117037226 | chr8:9134088-9134089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568817232 | chr8:9134108-9134109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76382817 | chr8:9134151-9134152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1870787 | chr8:9134157-9134158 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs11249912 | chr8:9134180-9134181 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs536383217 | chr8:9134181-9134182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112248943 | chr8:9134182-9134183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573408162 | chr8:9134189-9134190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545589651 | chr8:9134222-9134223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559154119 | chr8:9134227-9134228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs62493778 | chr8:9134252-9134253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73199674 | chr8:9134289-9134290 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs544894368 | chr8:9134290-9134291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184667084 | chr8:9134291-9134292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576179659 | chr8:9134307-9134308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529682029 | chr8:9134328-9134329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540000059 | chr8:9134380-9134381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs556679634 | chr8:9134382-9134383 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188736440 | chr8:9134388-9134389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs193259748 | chr8:9134390-9134391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7824926 | chr8:9134446-9134447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562312009 | chr8:9134485-9134486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184984113 | chr8:9134489-9134490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148022518 | chr8:9134492-9134493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567596197 | chr8:9134503-9134504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536650462 | chr8:9134513-9134514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546634365 | chr8:9134532-9134533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34203905 | chr8:9134563-9134564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374834840 | chr8:9134570-9134571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141695076 | chr8:9134574-9134575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189020052 | chr8:9134578-9134579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs330027 | chr8:9134584-9134585 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs115777841 | chr8:9134589-9134590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555297938 | chr8:9134590-9134591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546988563 | chr8:9134595-9134596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111582082 | chr8:9134613-9134614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11783632 | chr8:9134637-9134638 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs559856749 | chr8:9134659-9134660 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576890463 | chr8:9134660-9134661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545468883 | chr8:9134669-9134670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:9129600-9141200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr8:9133600-9135000 | Enhancers | Fetal Heart | heart |
3 | chr8:9134800-9135000 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr8:9136000-9136200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr8:9138000-9138400 | Enhancers | Brain Germinal Matrix | brain |
6 | chr8:9138200-9138800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr8:9138400-9138800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr8:9139600-9143000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr8:9140200-9143800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr8:9142800-9143000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
11 | chr8:9143000-9143200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr8:9143000-9144000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr8:9143000-9144200 | Enhancers | K562 | blood |
14 | chr8:9143800-9144200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr8:9148200-9148600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr8:9148600-9149600 | Enhancers | Fetal Intestine Small | intestine |
17 | chr8:9148600-9150400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr8:9148800-9150400 | Enhancers | Fetal Intestine Large | intestine |
19 | chr8:9149200-9149400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr8:9149200-9150400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
21 | chr8:9149200-9156400 | Enhancers | Fetal Heart | heart |
22 | chr8:9149400-9150200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
23 | chr8:9149400-9150200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
24 | chr8:9150200-9150400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
25 | chr8:9150200-9150600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
26 | chr8:9150200-9151000 | Enhancers | Right Atrium | heart |
27 | chr8:9150400-9160200 | Weak transcription | Fetal Intestine Large | intestine |
28 | chr8:9151000-9152800 | Weak transcription | Right Atrium | heart |